Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 May 1;339(Pt 3):579–588.

Expression of normal and truncated forms of human endoglin.

U Raab 1, B Velasco 1, P Lastres 1, A Letamendía 1, C Calés 1, C Langa 1, E Tapia 1, J P López-Bote 1, E Páez 1, C Bernabéu 1
PMCID: PMC1220193  PMID: 10215596

Abstract

Endoglin is a transmembrane glycoprotein 633 residues in length expressed at the surface of endothelial cells as a disulphide-linked homodimer; the specific cysteine residues involved in endoglin dimerization are unknown. Mutations in the coding region of the endoglin gene are responsible for hereditary haemorrhagic telangiectasia type 1 (HHT1), a dominantly inherited vascular disorder. Many of these mutations, if translated, would lead to truncated forms of the protein. It is therefore of interest to assess the protein expression of different truncated forms of endoglin. Infections in vitro or in vivo with recombinant vaccinia virus, as well as transient transfections with expression vectors, were used to express normal and truncated forms of endoglin. Truncated mutants could be classified into three different groups: (1) those that did not produce stable transcripts; (2) those that produced stable transcripts but did not secrete the protein; and (3) those that secreted a soluble dimeric protein. This is the first time that a recombinant truncated form of endoglin has been found to be expressed in a soluble form. Because a chimaeric construct encoding the N-terminal sequence of platelet/endothelial cell adhesion molecule (PECAM-1) antigen fused to residues Ile281-Ala658 of endoglin also yielded a dimeric surface protein, these results suggest that cysteine residues contained within the fragment Cys330-Cys412 are involved in disulphide bond formation. Infection with vaccinia recombinants encoding an HHT1 mutation did not affect the expression of the normal endoglin, and did not reveal an association of the recombinant soluble form with the transmembrane endoglin, supporting a haploinsufficiency model for HHT1.

Full Text

The Full Text of this article is available as a PDF (297.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellón T., Corbí A., Lastres P., Calés C., Cebrián M., Vera S., Cheifetz S., Massague J., Letarte M., Bernabéu C. Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol. 1993 Sep;23(9):2340–2345. doi: 10.1002/eji.1830230943. [DOI] [PubMed] [Google Scholar]
  2. Blann A. D., Wang J. M., Wilson P. B., Kumar S. Serum levels of the TGF-beta receptor are increased in atherosclerosis. Atherosclerosis. 1996 Feb;120(1-2):221–226. doi: 10.1016/0021-9150(95)05713-7. [DOI] [PubMed] [Google Scholar]
  3. Cabañas C., Sanchez-Madrid F., Bellon T., Figdor C. G., Te Velde A. A., Fernandez J. M., Acevedo A., Bernabeu C. Characterization of a novel myeloid antigen regulated during differentiation of monocytic cells. Eur J Immunol. 1989 Aug;19(8):1373–1378. doi: 10.1002/eji.1830190804. [DOI] [PubMed] [Google Scholar]
  4. Cheifetz S., Bellón T., Calés C., Vera S., Bernabeu C., Massagué J., Letarte M. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem. 1992 Sep 25;267(27):19027–19030. [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. Fernández-Ruiz E., St-Jacques S., Bellón T., Letarte M., Bernabéu C. Assignment of the human endoglin gene (END) to 9q34-->qter. Cytogenet Cell Genet. 1993;64(3-4):204–207. doi: 10.1159/000133576. [DOI] [PubMed] [Google Scholar]
  7. Gallione C. J., Klaus D. J., Yeh E. Y., Stenzel T. T., Xue Y., Anthony K. B., McAllister K. A., Baldwin M. A., Berg J. N., Lux A. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat. 1998;11(4):286–294. doi: 10.1002/(SICI)1098-1004(1998)11:4<286::AID-HUMU6>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  8. Ge A. Z., Butcher E. C. Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-beta ligand. Gene. 1994 Jan 28;138(1-2):201–206. doi: 10.1016/0378-1119(94)90808-7. [DOI] [PubMed] [Google Scholar]
  9. Gougos A., Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol. 1988 Sep 15;141(6):1925–1933. [PubMed] [Google Scholar]
  10. Gougos A., Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem. 1990 May 25;265(15):8361–8364. [PubMed] [Google Scholar]
  11. Gougos A., St Jacques S., Greaves A., O'Connell P. J., d'Apice A. J., Bühring H. J., Bernabeu C., van Mourik J. A., Letarte M. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol. 1992 Jan;4(1):83–92. doi: 10.1093/intimm/4.1.83. [DOI] [PubMed] [Google Scholar]
  12. Guttmacher A. E., Marchuk D. A., White R. I., Jr Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995 Oct 5;333(14):918–924. doi: 10.1056/NEJM199510053331407. [DOI] [PubMed] [Google Scholar]
  13. Haruta Y., Seon B. K. Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7898–7902. doi: 10.1073/pnas.83.20.7898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Johnson D. W., Berg J. N., Baldwin M. A., Gallione C. J., Marondel I., Yoon S. J., Stenzel T. T., Speer M., Pericak-Vance M. A., Diamond A. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996 Jun;13(2):189–195. doi: 10.1038/ng0696-189. [DOI] [PubMed] [Google Scholar]
  15. Lastres P., Bellon T., Cabañas C., Sanchez-Madrid F., Acevedo A., Gougos A., Letarte M., Bernabeu C. Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol. 1992 Feb;22(2):393–397. doi: 10.1002/eji.1830220216. [DOI] [PubMed] [Google Scholar]
  16. Lastres P., Letamendía A., Zhang H., Rius C., Almendro N., Raab U., López L. A., Langa C., Fabra A., Letarte M. Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol. 1996 Jun;133(5):1109–1121. doi: 10.1083/jcb.133.5.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. López-Casillas F., Cheifetz S., Doody J., Andres J. L., Lane W. S., Massagué J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell. 1991 Nov 15;67(4):785–795. doi: 10.1016/0092-8674(91)90073-8. [DOI] [PubMed] [Google Scholar]
  18. López-Guerrero J. A., López-Bote J. P., Ortiz M. A., Gupta R. S., Páez E., Bernabeu C. Modulation of adjuvant arthritis in Lewis rats by recombinant vaccinia virus expressing the human 60-kilodalton heat shock protein. Infect Immun. 1993 Oct;61(10):4225–4231. doi: 10.1128/iai.61.10.4225-4231.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Maquat L. E. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA. 1995 Jul;1(5):453–465. [PMC free article] [PubMed] [Google Scholar]
  20. Massagué J. Identification of receptors for type-beta transforming growth factor. Methods Enzymol. 1987;146:174–195. doi: 10.1016/s0076-6879(87)46020-5. [DOI] [PubMed] [Google Scholar]
  21. McAllister K. A., Baldwin M. A., Thukkani A. K., Gallione C. J., Berg J. N., Porteous M. E., Guttmacher A. E., Marchuk D. A. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet. 1995 Oct;4(10):1983–1985. doi: 10.1093/hmg/4.10.1983. [DOI] [PubMed] [Google Scholar]
  22. McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., Helmbold E. A., Markel D. S., McKinnon W. C., Murrell J. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994 Dec;8(4):345–351. doi: 10.1038/ng1294-345. [DOI] [PubMed] [Google Scholar]
  23. Moss B., Flexner C. Vaccinia virus expression vectors. Annu Rev Immunol. 1987;5:305–324. doi: 10.1146/annurev.iy.05.040187.001513. [DOI] [PubMed] [Google Scholar]
  24. Newman P. J. The biology of PECAM-1. J Clin Invest. 1997 Dec 1;100(11 Suppl):S25–S29. [PubMed] [Google Scholar]
  25. Pece N., Vera S., Cymerman U., White R. I., Jr, Wrana J. L., Letarte M. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest. 1997 Nov 15;100(10):2568–2579. doi: 10.1172/JCI119800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pichuantes S., Vera S., Bourdeau A., Pece N., Kumar S., Wayner E. A., Letarte M. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens. 1997 Sep;50(3):265–276. doi: 10.1111/j.1399-0039.1997.tb02870.x. [DOI] [PubMed] [Google Scholar]
  27. Robledo M. M., Hidalgo A., Lastres P., Arroyo A. G., Bernabeu C., Sánchez-Madrid F., Teixidó J. Characterization of TGF-beta 1-binding proteins in human bone marrow stromal cells. Br J Haematol. 1996 Jun;93(3):507–514. doi: 10.1046/j.1365-2141.1996.d01-1698.x. [DOI] [PubMed] [Google Scholar]
  28. Rokhlin O. W., Cohen M. B., Kubagawa H., Letarte M., Cooper M. D. Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J Immunol. 1995 May 1;154(9):4456–4465. [PubMed] [Google Scholar]
  29. Shovlin C. L., Hughes J. M., Scott J., Seidman C. E., Seidman J. G. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet. 1997 Jul;61(1):68–79. doi: 10.1086/513906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shovlin C. L. Molecular defects in rare bleeding disorders: hereditary haemorrhagic telangiectasia. Thromb Haemost. 1997 Jul;78(1):145–150. [PubMed] [Google Scholar]
  31. St-Jacques S., Cymerman U., Pece N., Letarte M. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. Endocrinology. 1994 Jun;134(6):2645–2657. doi: 10.1210/endo.134.6.8194490. [DOI] [PubMed] [Google Scholar]
  32. Yamaguchi H., Azuma H., Shigekiyo T., Inoue H., Saito S. A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia. Thromb Haemost. 1997 Feb;77(2):243–247. [PubMed] [Google Scholar]
  33. Yamashita H., Ichijo H., Grimsby S., Morén A., ten Dijke P., Miyazono K. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta. J Biol Chem. 1994 Jan 21;269(3):1995–2001. [PubMed] [Google Scholar]
  34. Zhang H., Shaw A. R., Mak A., Letarte M. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells. J Immunol. 1996 Jan 15;156(2):564–573. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES